AUS
NZ
UK
CA
USA
IND
Healthcare
Pro Medicus shares sport a P/E ratio above 100. Is this overly expensive?
October 30, 2023 06:46 PM AEDT| By Team Kalkine MediaIn the ever-evolving landscape of the stock market, one company has been making headlines for its extraordinary performance. Pro Medicus Ltd (,ASX: PME,) has seen its shares soar, with a remarkable 40% increase in 2023 and an astounding 630% surge ov...
ResMed's 36 % Share price Drop: CEO Assesses Ozempic and GLP-1 Impact
October 27, 2023 05:50 PM AEDT| By Team Kalkine MediaResMed Inc (ASX: RMD) has recently reported its 1Q FY24 results, with a 36% share price drop in the past six months. While the financials appear robust, concerns about the impact of Ozempic and GLP-1 medications on ResMed's business have raised inves...
An insider recently acquired more CSL shares; should you follow suit?
October 24, 2023 10:33 PM AEDT| By Team Kalkine MediaCSL Limited (,ASX: CSL,), one of Australia's leading healthcare companies, has faced challenges in recent months, resulting in a decline in its share price. Concerns over a slower margin recovery and the emergence of Ozempic as a potential treatment...
Citi predicts ResMed shares could increase by 70% in the next 12 months
October 24, 2023 09:36 PM AEDT| By Team Kalkine MediaWhile several,ASX healthcare stocks,have experienced fluctuations in their share prices, ResMed Inc. (ASX: RMD) recently faced a 2% dip, trading at $22.90 during Tuesday's afternoon session. This decline might represent a compelling buying opportunit...
ASX Healthcare Stocks Surge: Immutep Ltd Gains 16% on 'Promising' Results
October 23, 2023 05:57 PM AEDT| By Team Kalkine MediaThe,ASX healthcare stocks,sector is witnessing an exciting development as Immutep Ltd (ASX: IMM) shares surge by 16% in morning trade to reach 32 cents. What's behind this significant increase in the ASX All Ords biotech stock's value?,Investors are...
Telix Pharmaceuticals Share Price Falls 12% Despite Revenue Surge
October 19, 2023 10:00 PM AEDT| By Team Kalkine MediaInvestors are reacting strongly to the latest quarterly results and trial findings, causing the Telix Pharmaceuticals Ltd (,ASX: TLX,) share price to tumble by 12% in afternoon trade, down to $9.04 per share. This decline is having a notable impact o...
Citi Predicts a 40% Upside Potential for CSL Limited (ASX: CSL) Shares
October 19, 2023 09:23 PM AEDT| By Team Kalkine MediaCSL Limited (ASX: CSL) shares are currently experiencing a challenging trading session, with a 2% drop in the biotherapeutics company's stock, bringing it to $234.43 in afternoon trade. This decline means,ASX CSL shares,have fallen by approximately 2...
Three ASX healthcare Shares Surge 10% to 22% on Recent News
October 18, 2023 04:15 AM AEDT| By Team Kalkine MediaIn recent trading sessions, several,ASX healthcare shares,have witnessed substantial gains, with notable increases ranging from 10% to 22%. Investors are responding positively to the latest updates from Mayne Pharma Group Ltd (ASX: MYX), Paradigm Bio...
Volpara Health Technologies' Share Price Surges 13% on Strong Quarterly Update
October 18, 2023 12:44 AM AEDT| By Team Kalkine MediaInvestors in,ASX healthcare stocks,are witnessing a remarkable surge in the share price of Volpara Health Technologies Ltd (ASX: VHT), which has climbed by 13% to 72.5 cents in afternoon trade on Tuesday. The health technology company's shares are at...
Why ASX 200 Healthcare Stocks are Set for Fresh Growth
October 17, 2023 10:53 PM AEDT| By Team Kalkine MediaOver the past year, the S&P/ASX 200 Index (ASX: XJO) has witnessed a 6% gain, showcasing the resilience of the Australian stock market. However, the healthcare sector, as represented by the S&P/ASX 200 Health Care Index (ASX: XHJ), has diverged from...
ASX Healthcare Stock Dimerix Ltd (ASX: DXB) Soars 280% in Two-Day Rally
October 10, 2023 08:42 PM AEDT| By Team Kalkine MediaThe Dimerix Ltd (ASX: DXB) share price continues its impressive rally, marking a second consecutive day of strong gains. At one point today, the,ASX healthcare stock,reached a new 52-week high of 23 cents, representing a remarkable 48% surge. This re...
ASX Healthcare Stock Soars 18% Today—Guess Which One?
October 10, 2023 08:40 PM AEDT| By Team Kalkine MediaThe,ASX healthcare stocks,witnessed a notable surge today, and leading the charge was Paradigm Biopharmaceuticals Ltd. The company's stock experienced a remarkable upswing, gaining over 18% at one point, reaching 73.5 cents.,Investor interest in Para...
Decoding CSL Share Price's July Decline: Let's Uncover the Reasons!
August 02, 2023 07:10 AM AEST| By Team Kalkine MediaThe share price of CSL Limited (ASX: CSL), a leading global biotechnology company, experienced a notable decline in the month of July, prompting investors and market analysts to seek out the underlying reasons behind this downturn. As one of the larg...
_07_24_2023_12_36_20_648044.jpg)
ASX Healthcare Stocks: Medibio Soars 50% on Phase 1 Results; Cann Doubles Cannabis Harvest
July 25, 2023 07:15 AM AEST| By Team Kalkine MediaIn the world of,ASX healthcare stocks,, the cannabis sector has been making headlines with significant developments from companies like Medibio Limited (ASX: MEB) and Cann Group Limited (ASX: CAN). These companies have witnessed impressive growth and...
_07_24_2023_11_23_20_856099.png)
CSL (ASX: CSL) expects organic growth to be driven by Vifor integration
July 24, 2023 09:13 PM AEST| By Team Kalkine MediaCSL expects growth in plasma collection and immunoglobulins sales driven by the acquisitions.
_07_20_2023_11_27_15_536404.jpg)
ASX Health Stocks: Neuren Pharma Surges 16% on Acadia Worldwide Licence.
July 21, 2023 06:55 AM AEST| By Team Kalkine MediaIn a recent market development, ASX Health Stocks have witnessed significant activity, with Neuren Pharmaceuticals Ltd (ASX: NEU) taking the spotlight. The company's shares surged an impressive 16% after announcing a worldwide license agreement with...
_07_18_2023_10_40_01_522789.jpg)
PYC's Phase 2 Clinical Trial Progress: Successful Toxicology Tests Boost ASX Health Stocks
July 19, 2023 07:15 AM AEST| By Team Kalkine MediaPYC Therapeutics Limited (ASX: PYC), a biotechnology company focused on developing gene therapies for genetic diseases, has recently achieved a significant milestone in its Phase 2 clinical trial. The successful completion of toxicology tests for its...
_07_14_2023_06_42_51_328943.jpg)
Shareholders of EMVision Medical Devices (ASX: EMV) have Gained 11% in the Past Week
July 14, 2023 04:40 PM AEST| By Team Kalkine MediaShareholders of EMVision Medical Devices (ASX: EMV) have experienced a notable gain of 11% in the past week. This positive performance reflects the upward momentum of the company's shares and highlights the potential opportunities within,ASX healthca...
_07_12_2023_05_01_34_210210.jpg)
ImpediMed (ASX:IPD): Can It Fulfill Its Growth Plans Successfully?
July 12, 2023 02:56 PM AEST| By Team Kalkine MediaImpediMed (ASX:IPD) is a healthcare company listed on the ASX that specializes in the development and commercialization of medical devices for non-invasive fluid management. With its unique technology, ImpediMed aims to provide solutions for patients...
Record-Breaking Performance: Three ASX Healthcare Stocks Achieve Phenomenal Growth of 20% to 100% Today
July 04, 2023 04:47 PM AEST| By Team Kalkine MediaASX healthcare stocks,that have delivered remarkable growth, ranging from 20% to 100% in a single day. These companies have demonstrated their potential to outperform the market and have caught the attention of investors seeking lucrative opportuniti...
Advertise your brand on Kalkine Media